Centogene NV (CNTG) has a profit margin of -85.68%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2023
Trailing 12 months ending Sep 2023
Centogene NV (CNTG) currently reports a profit margin of -85.68% as of September 2023. That compares with -49.68% in the prior-year period — down 72.5% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Centogene NV's profit margin history and peer comparisons.
Centogene NV's profit margin decreased from -49.68% to -85.68% — a 72.5% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Centogene NV's profit margin of -85.68% is lower than the Healthcare sector average of 14.34%. That is roughly 697.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Centogene NV's current -85.68% should be judged against Healthcare norms (sector average: 14.34%) and against CNTG's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -85.68%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Centogene NV, and consider following CNTG for alerts when major investors trade the stock.